Wall Street Looks Ahead: Market-Moving Events that Will Shape 2007
This article was originally published in RPM Report
Executive Summary
Wall Street analysts are confident that Congress will pass drug safety legislation this year, but in a poll conducted by The RPM Report, they didn't agree on much else. The panel was split most other questions-from whether Congress would remove the "non-interference" clause under Medicare Part D to whether FDA would approve another cox-2 inhibitor.